Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
deep vein thrombosis (DVT)
MedTech
E2 lands $80M series C for next-gen thrombectomy treatment
E2 has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment.
Ben Adams
Apr 7, 2026 10:28am
FDA clears muscle stimulator for boosting blood flow in the legs
Dec 20, 2021 10:05am
Philips gets the blood flowing with Vesper Medical tuck-in buy
Dec 14, 2021 11:05am
Surmodics gets the blood flowing with $40M thrombectomy deal
Jul 7, 2021 10:05am
FDA expedites Fresenius dialysis machine made to prevent clots
Oct 28, 2019 12:14pm
Boston Scientific buys up vein stent maker Veniti in $160M deal
Aug 8, 2018 10:27am
